Dr. Gheorghiade is a professor of Medicine and Surgery, associate chief of the Division of Cardiology, chief of the Cardiology Clinical Service, and director of the Telemetry Unit at Northwestern University's Feinberg School of Medicine.
He obtained his MD, Magna Cum Laude, from the University of Rome in 1972 and did his training in internal medicine and cardiology at Brown University. Subsequently, he moved to Virginia, where he became chief of Cardiology at the Salem VA and associate professor of Medicine at the University of Virginia. Then, he became chief of the Cardiac Intensive Care Unit at the Henry Ford Hospital in Detroit, Michigan and associate professor of Clinical Medicine at the University of Michigan. From there, he moved to his current position in Chicago at Northwestern. Dr. Gheorghiade was a visiting professor at the major universities in the United States and abroad and received numerous awards for teaching both medical students and residents.
He is a member of many national and international committees and serves on the editorial board of many journals including the American Heart Journal, The American Journal of Cardiology, The Journal of the American College of Cardiology and Circulation: Heart Failure journal. Dr. Gheorghiade served as a guest editor on numerous occasions for the American Journal of Cardiology, American Heart Journal, and American Journal of Medicine.
He was chairman of the Steering Committee for many heart failure clinical research trials including OPTIME, ACTIV, IMPACT, PRESERVD, STEP-CHF and HORIZON HF. He is co-chairing the international EVEREST and ECLIPSE trials and was a member of the Steering Committee of RADIANCE, FIRST, CARS, RITZ 4, EPHESUS and OPTIMIZE-HF. He presently is the chair of the international ASTRONAUT, RENO-DEFEND, and co-chair of the IGNITE trials.
Dr. Gheorghiade is the author of more than 500 publications and more than 300 original presentations at national and international meetings. He was the chairman/co-chairman of numerous international and national meetings. He recently was the co-editor of two comprehensive textbooks on Acute Heart Failure Syndromes. At present, his research interests are related to the pathophysiology, prognosis, and management of hospitalized patients with heart failure and the roles of vasopressin antagonist, newer inotropes, adenosine blocking agents, and other new agents in acute heart failure in heart failure. His major goal is to improve the post discharge outcomes in patients hospitalized with Acute Heart Failure Syndromes.